Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR ...
As the federal health emergency ended May 11 and COVID numbers are on the rise, here’s how you can still access tests, at-home and PCR. (Michael Bocchieri/Getty Images) It’s that time again: COVID-19 ...
For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...
In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...
A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...
WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...
The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...
Please provide your email address to receive an email when new articles are posted on . University CMV testing among newborns is not common. In Minnesota, the first state with universal CMV testing, a ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results